MiR-200c synergizes with trastuzumab-loaded gold nanoparticles to overcome resistance in ovarian cancer cells
Authors:
- Tommaso A. SalamoneTSTommaso A. Salamone
- Sofia MarottaSMSofia Marotta
- Stella MrmićSMStella Mrmić
Open Access
- 16 June 2025
- journal article
- research article
- Published by Springer Nature in Cancer Nanotechnology
- Vol. 16 (1) , 1-19
Abstract
No abstract availableKeywords
Funding Information
- Sapienza grant (RM12218167C322C1, RM123188E8E9A26E)
- LILT - Lega Italiana per la Lotta contro i Tumori
- PRIN 2022
This publication has 40 references indexed in Scilit:
- Bromelain-facilitated GNPs: A strategic innate anticancer delivery system for methotrexate into osteosarcoma cellsColloids and Surfaces A: Physicochemical and Engineering Aspects, 2024
- Green synthesis of anti-cancer drug-loaded gold nanoparticles for low-intensity pulsed ultrasound targeted drug releaseDrug Delivery and Translational Research, 2024
- Use of Silica Nanoparticles for Drug Delivery in Cardiovascular DiseaseClinical Therapeutics, 2023
- Thiol functionalised gold nanoparticles loaded with methotrexate for cancer treatment: From synthesis to in vitro studies on neuroblastoma cell linesJournal of Colloid and Interface Science, 2023
- Nanomaterials: An overview of synthesis, classification, characterization, and applicationsNano Select, 2023
- Hydrophilic Gold Nanoparticles as Anti‐PD‐L1 Antibody Carriers: Synthesis and Interface PropertiesParticle & Particle Systems Characterization, 2022
- Nanoparticle processing: Understanding and controlling aggregationAdvances in Colloid and Interface Science, 2020
- Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesisGenes & Diseases, 2018
- Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biologyAdvanced Drug Delivery Reviews, 2014
- Molecularly targeted gold nanoparticles enhance the radiation response of breast cancer cells and tumor xenografts to X-radiationBreast Cancer Research and Treatment, 2012